Abstract
Pneumonia is an infection of the lung parenchyma and defined as combination of a novel radiological infiltrate with typical signs and symptoms. There are 3 distinguished entities of pneumonia: community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and pneumonia in the immunocompromised patient. The spectrum of pathogens is increasing from CAP, mostly caused by pneumococci, over HAP (additional multi-drug resistant pathogens) to pneumonia in the immunocompromised (additional opportunistic pathogens). Therefore, each entity demands a specific diagnostic and therapeutic approach. This review compares the 3 forms of pneumonia and presents a guideline based clinical approach in the context of current studies.
© Georg Thieme Verlag KG Stuttgart · New York.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use
-
Coinfection / diagnosis
-
Coinfection / drug therapy
-
Coinfection / epidemiology
-
Community-Acquired Infections / diagnosis*
-
Community-Acquired Infections / drug therapy
-
Community-Acquired Infections / epidemiology
-
Cross Infection / diagnosis*
-
Cross Infection / drug therapy
-
Cross Infection / epidemiology
-
Cross-Sectional Studies
-
Drug Resistance, Multiple, Bacterial
-
Germany
-
Humans
-
Intensive Care Units
-
Opportunistic Infections / diagnosis*
-
Opportunistic Infections / drug therapy
-
Opportunistic Infections / epidemiology
-
Pneumonia, Bacterial / diagnosis*
-
Pneumonia, Bacterial / drug therapy
-
Pneumonia, Bacterial / epidemiology
-
Pneumonia, Pneumococcal / diagnosis
-
Pneumonia, Pneumococcal / drug therapy
-
Pneumonia, Pneumococcal / epidemiology
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / epidemiology
-
Prognosis
-
Risk Factors